Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cardinal Health (NY: CAH )

96.96 -1.50 (-1.52%)
Streaming Delayed Price Updated: 10:17 AM EDT, May 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Cardinal Health

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Benzinga's Top Ratings Upgrades, Downgrades For May 26, 2022
Upgrades 
Via Benzinga
The 7 Highest-Yielding Dividend Stocks to Buy Now for Income
These are the highest-yielding dividend stocks to invest in now. Each company offers investors a gateway to tap into significant yields. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For May 18, 2022
Via Benzinga
Cardinal Health's Shares Fall as Inflation and Supply Chain Constraints Hit Q3 Earnings
Via Benzinga
Dividend Income Update April 2022
With May already underway it is time for all dividend income investors to look back at the previous month and see how much passive dividend income their portfolios generated. 
Via Talk Markets
7 Stock Picks to Play the Post-Pandemic Return of Dental Visits
The two years away from the “chair” could cynically boost these oral health plays. 
Via InvestorPlace
Walgreens Announces $683M Opioid Settlement With Florida
Via Benzinga
Cardinal Health: Q3 Earnings Insights
Cardinal Health (NYSE:CAH) reported its Q3 earnings results on Thursday, May 5, 2022 at 06:45 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Washington, Drug Distributors Reach $518M Settlement For Opioid Claims
Via Benzinga
Should Value Investors Pick Cardinal Health (CAH) Stock Now?
Cardinal Health is an inspired choice for value investors, as it is hard to beat its incredible lineup of statistics on this front. 
Via Talk Markets
Expert Ratings For Cardinal Health
Analysts have provided the following ratings for Cardinal Health (NYSE:CAH) within the last quarter: 
Via Benzinga
Where Cardinal Health Stands With Analysts
Analysts have provided the following ratings for Cardinal Health (NYSE:CAH) within the last quarter: 
Via Benzinga
San Francisco To Start Opioid Epidemic Trial Against Teva, Walgreen: Reuters
Via Benzinga
President Biden To Outline Strategy To Tackle Drug Addiction, Overdose: Reuters
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 12, 2022
Upgrades 
Via Benzinga
Recap: Cardinal Health Q2 Earnings
  Cardinal Health (NYSE:CAH) reported its Q2 earnings results on Thursday, February 3, 2022 at 06:45 AM. Here's what investors need to know about the announcement. 
Via Benzinga
10 Stocks That Moved From Thursday's CNBC's 'Fast Money: Halftime Report'
CNBC’s "Fast Money: Halftime Report" delivers market-moving news to investors. 
Via Benzinga
Hostess Brands Appoints Travis Leonard As Finance Chief
Hostess Brands Inc (NASDAQ: TWNK) has appointed Travis Leonard as the Chief Financial Officer (CFO), effective May 11, 2022. Leonard will succeed interim CFO... 
Via Benzinga
West Virginia Says J&J, Teva, AbbVie Caused 'Tsunami' Of Opioid Addiction: Reuters
West Virginia's attorney general urged a judge to hold Johnson & Johnson (NYSE: JNJ), Teva Pharmaceuticals Industries Ltd (NYSE: TEVA), and AbbVie Inc's (NYSE: 
Via Benzinga
This Favorable Sign Appears On Cardinal Health's Chart
If history is any guide, there may be good fortune ahead for shares of Cardinal Health (NYSE:CAH). A so-called "golden cross" has formed on its chart and, not surprisingly, this... 
Via Benzinga
High Inflation And Dividend Stocks: Is It Time For Coca-Cola And Exxon Mobil To Shine?
One potential way for investors to offset the impact of inflation is to look to stocks with high dividend yields. 
Via Talk Markets
Earnings Scheduled For February 3, 2022
Companies Reporting Before The Bell • Tuesday Morning (NASDAQ:TUEM) is likely to report earnings for its second quarter. 
Via Benzinga
High Inflation And Dividend Stocks: Is It Time For Coca-Cola And Exxon Mobil To Shine?
Inflation can be a nuisance for investors, eating away at portfolio returns. The U.S. Labor Department reported a 7.5% increase in the consumer pri... 
Via Benzinga
Johnson & Johnson Sees A Strong Move: Is It Ready For A Breakout?
Johnson & Johnson (NYSE:JNJ) shares are trading high... 
Via Benzinga
Drug Distributors, JNJ Agree To Settle $26B Opioid Lawsuits
Distributors McKesson Corporation (NYSE: MCK), AmerisourceBergen Corp (NYSE: ABC), Cardinal Health Inc (NYSE: CAH), and Johnson & Johnson (NYSE:... 
Via Benzinga
Dividend Income Update January 2022
With February already underway it is time for all dividend income investors to look back at the previous month and see how much passive dividend income our portfolios generated. 
Via Talk Markets
Daily Report: Cardinal Health (CAH)
CAH's recent $51.96 share price might rise by $4.04 to reach $56.00 by February 7, 2023. This estimate is just eight cents under the median of one-year target single share prices from 13 analysts... 
Via Talk Markets
Stock Market Rally Volatile; Google, Facebook, Amazon, Snap Are Earnings Movers: Weekly Review
The major indexes slashed weekly gains after Monday's follow-through day. 
Via Investor's Business Daily
Cardinal Health's Q4 Earnings Hit By Inflationary Impacts, Supply Chain Constraints; Lowers FY22 Outlook
Cardinal Health (NYSE: CAH) has reported Q2 FY22 adjuste 
Via Benzinga
Johnson & Johnson, Distributors Reach $590M Opioid Settlement For Tribe Claims: Report
Johnson & Johnson (NYSE: JNJ) and the three U.S. 
Via Benzinga
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.